• Home
  • Search Results
  • Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury.

Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury.

Cell metabolism (2020-02-01)
Arif Yurdagul, Manikandan Subramanian, Xiaobo Wang, Scott B Crown, Olga R Ilkayeva, Lancia Darville, Gopi K Kolluru, Christina C Rymond, Brennan D Gerlach, Ze Zheng, George Kuriakose, Christopher G Kevil, John M Koomen, John L Cleveland, Deborah M Muoio, Ira Tabas
ABSTRACT

Continual efferocytic clearance of apoptotic cells (ACs) by macrophages prevents necrosis and promotes injury resolution. How continual efferocytosis is promoted is not clear. Here, we show that the process is optimized by linking the metabolism of engulfed cargo from initial efferocytic events to subsequent rounds. We found that continual efferocytosis is enhanced by the metabolism of AC-derived arginine and ornithine to putrescine by macrophage arginase 1 (Arg1) and ornithine decarboxylase (ODC). Putrescine augments HuR-mediated stabilization of the mRNA encoding the GTP-exchange factor Dbl, which activates actin-regulating Rac1 to facilitate subsequent rounds of AC internalization. Inhibition of any step along this pathway after first-AC uptake suppresses second-AC internalization, whereas putrescine addition rescues this defect. Mice lacking myeloid Arg1 or ODC have defects in efferocytosis in vivo and in atherosclerosis regression, while treatment with putrescine promotes atherosclerosis resolution. Thus, macrophage metabolism of AC-derived metabolites allows for optimal continual efferocytosis and resolution of injury.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Glycine, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
L-Glutamic acid, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
L-Methionine, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
L-Proline, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
L-Arginine monohydrochloride, reagent grade, ≥98% (HPLC), powder
Sigma-Aldrich
L-Tyrosine, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
L-Phenylalanine, reagent grade, ≥98%
Sigma-Aldrich
Neomycin solution, with 10 mg/mL neomycin in 0.9% NaCl, 0.1 μm filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
L-Aspartic acid, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
L-Alanine, ≥98% (TLC)
Sigma-Aldrich
L-Serine, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
L-Valine, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
Cytochalasin D, from Zygosporium mansonii, ≥98% (TLC and HPLC), powder
Sigma-Aldrich
L-Citrulline, ≥98% (TLC)
Sigma-Aldrich
Putrescine dihydrochloride, ≥98% (TLC)
Sigma-Aldrich
N-Ethylmaleimide, BioUltra, ≥99.0% (HPLC)
Sigma-Aldrich
Diluent C for General Membrane Labeling, Distributed for Phanos Technologies
Sigma-Aldrich
Nitric oxide, 98.5%
Sigma-Aldrich
O-Acetyl-L-carnitine hydrochloride, ≥99% (titration), powder
Sigma-Aldrich
IL-4 from mouse, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Sigma-Aldrich
Palmitoyl-DL-carnitine chloride, powder
Sigma-Aldrich
Dexamethasone - CAS 50-02-2 - Calbiochem, Most active and highly stable glucocorticoid.
Sigma-Aldrich
L-Valine-d8, ≥98 atom % D, ≥98% (CP)
Sigma-Aldrich
2,2,3,4,4,4-Hexafluorobutyl acrylate, 95%
Sigma-Aldrich
Interleukin-13 from mouse, ≥97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
Sigma-Aldrich
L-Ornithine monohydrochloride, BioXtra, ≥99%
Sigma-Aldrich
RIPAb+ HuR - RIP Validated Antibody and Primer Set, from rabbit
Supelco
Isovaleryl-L-carnitine, analytical standard
Sigma-Aldrich
Anti-ARG1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-19S regulator non-ATPase subunit S5a/Rpn10 Antibody, clone S5a-18, clone S5a-18, Upstate®, from mouse

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.